Centenial Surgical Suture Share Price

  • 117.858.85 (8.11%)
  • Volume: 1,285
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:31 PM IST
Loading...

Centenial Surgical Sutu...

  • 117.858.85 (8.11%)
  • Volume: 1,285
Advertisment

Centenial Surg share price insights

View All
  • Sales de-grew by 2.78%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)

  • Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

  • Company has spent 4.82% of its operating revenues towards interest expenses and 22.14% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

  • Centenial Surgical Suture Ltd. share price moved up by 8.11% from its previous close of Rs 109.00. Centenial Surgical Suture Ltd. stock last traded price is 117.85

    Share PriceValue
    Today/Current/Last-117.85
    Previous Day-109.00

InsightsCentenial Surg

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    41.70
    EPS - TTM
    (₹)
    2.83
    MCap
    (₹ Cr.)
    43.00
    Sectoral MCap Rank
    40
    PB Ratio
    (x)
    1.23
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.00
    3 Months0.04
    6 Months0.00
    1 Year-0.03
    3 Years-0.09

    0.00
    VWAP
    (₹)
    115.16
    52W H/L
    (₹)
    160.00 / 73.46

    Centenial Surg Share Price Returns

    1 Day8.11%
    1 Week9.78%
    1 MonthN.A.
    3 Months8.12%
    1 Year54.68%
    3 Years117.84%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Centenial Surg belongs to analysts' top-rated companies list?

    View Stock Screeners

    Centenial Surg Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Centenial Surg Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Centenial Surg Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Topline Contraction

        Sales de-grew by 2.78%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent 4.82% of its operating revenues towards interest expenses and 22.14% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income13.7412.0812.4513.1213.67
      Total Income Growth (%)13.69-2.92-5.13-3.994.74
      Total Expenses12.8110.9811.5312.2712.79
      Total Expenses Growth (%)16.62-4.72-6.06-4.064.54
      EBIT0.931.100.920.850.87
      EBIT Growth (%)-15.5219.628.33-2.957.62
      Profit after Tax (PAT)0.300.190.310.240.29
      PAT Growth (%)56.78-37.9229.67-18.99107.62
      EBIT Margin (%)6.769.107.396.476.40
      Net Profit Margin (%)2.171.572.461.802.13
      Basic EPS (₹)0.820.520.840.650.80
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue51.3252.7844.4737.0355.71
      Total Revenue Growth (%)-2.7818.6920.11-33.53-0.66
      Total Expenses50.0451.3243.4035.5053.55
      Total Expenses Growth (%)-2.4918.2622.26-33.720.60
      Profit after Tax (PAT)1.130.890.630.961.30
      PAT Growth (%)28.0541.27-34.80-25.78-35.73
      Operating Profit Margin (%)7.305.936.679.607.80
      Net Profit Margin (%)2.211.681.412.602.33
      Basic EPS (₹)3.112.431.722.643.55

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets79.1566.4061.3470.0569.29
      Total Assets Growth (%)19.208.25-12.431.1022.08
      Total Liabilities46.9335.3231.1440.4740.68
      Total Liabilities Growth (%)32.8713.42-23.05-0.5241.69
      Total Equity32.2231.0830.2029.5728.61
      Total Equity Growth (%)3.672.912.133.361.96
      Current Ratio (x)1.992.042.201.921.87
      Total Debt to Equity (x)0.000.320.310.420.00
      Contingent Liabilities0.000.100.100.100.10

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 7.92 cr for investing activities which is an YoY increase of 4407.31%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities3.751.304.75-0.052.08
      Net Cash used in Investing Activities-7.92-0.18-0.17-0.89-1.31
      Net Cash flow from Financing Activities4.53-1.05-4.870.75-0.37
      Net Cash Flow0.350.07-0.28-0.180.40
      Closing Cash & Cash Equivalent0.680.330.260.540.72
      Closing Cash & Cash Equivalent Growth (%)107.4528.65-52.39-25.48121.61
      Total Debt/ CFO (x)0.007.651.96-254.100.00

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)3.522.852.073.254.52
      Return on Capital Employed (%)8.088.378.009.2011.31
      Return on Assets (%)1.431.331.021.371.87
      Interest Coverage Ratio (x)2.082.662.372.531.99
      Asset Turnover Ratio (x)0.700.820.680.5380.26
      Price to Earnings (x)43.8637.8852.6324.1514.58
      Price to Book (x)1.541.081.090.780.66
      EV/EBITDA (x)9.539.729.356.853.08
      EBITDA Margin (%)10.028.4010.1113.8010.59

      No reported Financial Ratios are available.

    Financial InsightsCentenial Surg

    • Income (P&L)
    • Cash Flow
      • Topline Contraction

        Sales de-grew by 2.78%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 4.82% of its operating revenues towards interest expenses and 22.14% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 7.92 cr for investing activities which is an YoY increase of 4407.31%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Centenial Surg Peer Comparison

    • Centenial Surg Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Centenial Surg41.701.333.528.081.4311.377.302.213.111.990.000.00
      Nureca Ltd523.491.56-0.92-1.04-0.87-21.85-2.23-1.95-1.7920.770.00-0.18
      Denis Chem Lab21.492.8213.8819.0810.2015.399.346.648.042.550.010.06
      Constronics Infra197.94128.5574.2412.0710.89-6.21101.1192.750.1053.655.73-32.58
      Shree Pacetronix23.495.1625.7636.6315.4442.3122.6215.239.331.850.34-36.36
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Transgene Biotek
      • GKB Ophthalmics
      • Bandaram Pharma Pack
      • Kretto Syscon
      • Span Divergent

      Choose from Stocks

      Peers InsightsCentenial Surg

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

      • Stock Returns vs BSE Healthcare

        Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Centenial Surg Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Centenial Surg Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters46.8946.8946.8946.89
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others53.1153.1153.1153.11
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters17,10,60146.89 %0.00
        Pledge00.00 %0.00
        Others19,37,69953.11 %0.00

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Centenial Surg Board Meeting/AGM

      • Centenial Surg Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 12, 2024Aug 05, 2024Board MeetingQuarterly Results & A.G.M.
        May 28, 2024May 21, 2024Board MeetingAudited Results
        Apr 29, 2024Apr 25, 2024Board MeetingOthers
        Feb 14, 2024Feb 07, 2024Board MeetingQuarterly Results
        Nov 14, 2023Oct 30, 2023Board MeetingQuarterly Results
      • Dividend announcements are not available.

      • No other corporate actions details are available.

      About Centenial Surg

      Centenial Surgical Suture Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 43.00 Crore) operating in Hospitals & Allied Services sector. Centenial Surgical Suture Ltd. key Products/Revenue Segments include Medical Equipments & Accessories for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • VM

        Vijay Majrekar

        Managing Director & CEO
        AK

        Anuradha Kashikar

        Executive Director & CFO
        DT

        Devraj T Poojary

        Executive Director
        BS

        Bhushan S Limaye

        Ind. Non-Executive Director
        Show More
      • Mahesh Chandra & Associates

      FAQs about Centenial Surg share

      • 1. What's the Centenial Surg share price today?
        Centenial Surg share price was Rs 117.85 as on 29 Aug, 2024, 03:31 PM IST. Centenial Surg share price was up by 8.11% based on previous share price of Rs 112.75. Centenial Surg share price trend:
        • Last 3 Months: Centenial Surg share price moved up by 8.12%
        • Last 12 Months: Centenial Surg share price moved up 54.68%
        • Last 3 Years: Centenial Surg Share price moved up by 117.84%
      • 2. What are the Centenial Surg quarterly results?
        Total Revenue and Earning for Centenial Surg for the year ending 2024-03-31 was Rs 51.32 Cr and Rs 1.13 Cr on Standalone basis. Last Quarter 2024-06-30, Centenial Surg reported an income of Rs 13.74 Cr and profit of Rs 0.30 Cr.
      • 3. Who's the owner of Centenial Surg?
        Following are the key changes to Centenial Surg shareholding:
        • Promoter holding has not changed in last 9 months and holds 46.89 stake as on 30 Jun 2024
        • Other investor holding has not changed in last 9 months and holds 53.11 stake as on 30 Jun 2024
      • 4. What are the returns for Centenial Surg share?
        Return Performance of Centenial Surg Shares:
        • 1 Week: Centenial Surg share price moved up by 9.78%
        • 3 Month: Centenial Surg share price moved up by 8.12%
        • 6 Month: Centenial Surg share price moved up by 12.61%
      • 5. What has been highest price of Centenial Surg share in last 52 weeks?
        Centenial Surg share price saw a 52 week high of Rs 160.00 and 52 week low of Rs 73.46.
      • 6. Who is the Chief Executive Officer of Centenial Surg?
        Vijay Majrekar is the Managing Director & CEO of Centenial Surg
      • 7. Which are the key peers to Centenial Surg?
        Within Hospitals & Allied Services sector Centenial Surg, Bandaram Pharma Packtech Ltd., Shree Pacetronix Ltd., GKB Ophthalmics Ltd., Kretto Syscon Ltd., Span Divergent Ltd., Transgene Biotek Ltd., Transpact Enterprises Ltd., Constronics Infra Ltd., Denis Chem Lab Ltd. and Nureca Ltd. are usually compared together by investors for analysis.
      • 8. What are the key metrics to analyse Centenial Surg Share Price?
        Centenial Surg share can be quickly analyzed on following metrics:
        • Stock's PE is 41.70
        • Price to Book Ratio of 1.23
      • 9. What's the market capitalization of Centenial Surg?
        Market Capitalization of Centenial Surg stock is Rs 43.00 Cr.
      • 10. What is the PE & PB ratio of Centenial Surg?
        The PE ratio of Centenial Surg stands at 38.57, while the PB ratio is 1.84.
      • 11. What is the CAGR of Centenial Surg?
        The CAGR of Centenial Surg is 8.5.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times